The move by the European Medicines Agency comes weeks after the same vaccine was authorised in Britain and the United States, prompting pressure from EU governments for the agency to speed up its process as virus cases surged again across the continent.
Valentin Bianchi/AP
The move by the European Medicines Agency comes weeks after the same vaccine was authorised in Britain and the United States, prompting pressure from EU governments for the agency to speed up its process as virus cases surged again across the continent.
Adding to an already grisly toll were concerns over a newly identified strain that appears to spread more easily. But experts expressed confidence that the new vaccine would still be effective against it.